Child and Adolescent Registry for Participants With Narcolepsy
← catalyst calendarSponsored by Jazz Pharmaceuticals (industry) · JAZZ — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
500estimated
Sites
25
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-10-10 | actual | When the study began enrolling |
| Primary completion | 2024-10-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2024-10-01 | estimated | The whole study's end, after follow-up |
| First posted | 2021-05-25 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-08-15 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Narcolepsy
Primary outcomes
what the primary-completion date above is the date OFImprove Understanding of Natural History of Pediatric Narcolepsy
measured Up to 4 years
Characterize the Presentation, Identification, and Diagnosis of Narcolepsy in Pediatric Participants
measured Up to 4 years
Understand Treatment Practices and Outcomes Captured by Treatment Regimen and Rational for Changes
measured Up to 4 years
Permalink · JAZZ's whole pipeline · Catalyst calendar · Every registered study · What changed